Controlling Counterfeit Medications

Similar documents
Charter on Access to Health in Developing Countries

Global Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015

Romania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide

Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare

Corporate Presentation & Offer for SAP ATTP December 2015

Global Forum on Competition

Taking a Leap Toward Global Supply Chain Efficiency - Part II

ECTA European Communities Trade Mark Association 24th Annual Meeting in LONDON

Pharmaceutical RFID: From Mandates to Endorsements and Laws

GS1 Ireland Healthcare User Group (HUG) Information Day

Customs-related aspects of the Rotterdam Convention Switzerland s experience. Secretariat of the Rotterdam Convention. Switzerland s experience

IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS. Pedro Ferreira ANF

Patients are Counting on Us: A Little Less Conversation It s Time to Act

Guidance Document. Meeting Requirements as a Registered Food Importer. A guidance document issued by the Ministry for Primary Industries

EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update

Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

The online counterfeit economy: consumer electronics

Orange and Yellow Guides

DRUG WHOLESALING AND IMPORTATION: CHALLENGES. AND OPPORTUNITIESt. Giacalone,: Drug Wholesaling and Importation: Challenges and Opportunities

Serialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION

A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland)

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges

It is unclear whether salmon tainted with such compounds is entering U.S. markets.

The interface between Good Clinical Practice and Good Manufacturing Practice

Serialization and epedigree: New Opportunities for Life Sciences Manufacturers

This article specifically covers incorporation of physical and chemical indicators (PCIDs) into or onto the drug product.

Presentation of Capabilities Reverse Logistics

GIRP comments on. The vital link in healthcare 1. European Association of Pharmaceutical Full-line Wholesalers

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update

Maximiliano Derecho. National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland

Security Printing Services

Data Reliability - Internet

Supplier Assurance Program. CBE Pty Ltd

Summary of Medicines Plan

GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS

Progress Report on Recommendations of 14 th International Conference of Drug Regulatory Authorities (ICDRA) from WHO South-East Asia Region (SEAR)

EAHP STATEMENT ON THE NEED FOR BARCODING OF THE SINGLE DOSE ADMINISTERED IN HOSPITALS

Security Engineering Services. Scalaris GRC Day 2011

Membership Registration Form. Company Details

MEDICAL NITROUS OXIDE AND ENTONOX COMPLIANCE

FDA Update on Compounding

Indian medicine manufacturer Medreich PLC improves production and quality with coding solutions from Videojet

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office

notifications regarding Anti Counterfeit Labelling Solutions

Saudi Drug Code (SDC), and Drug Barcoding Specifications

KNOW YOUR RUPAY DEBIT CARD

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland

Overview. A brief from

Company Profile User Guide

Four entry strategies for small and midsized companies

Anti-Slavery & Human Trafficking Report

Statements for Hill Briefing on FDA, India and Substandard Drugs February 26, 2014

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

Barcodes on Unit of Use

European Parliament resolution of 8 March 2011 on the revision of the General Product Safety Directive and market surveillance (2010/2085(INI))

A STUDY ON VARIATIONS IN PHARMACEUTICAL PRODUCTS IN PHILIPPINES AND VARITAION POLICIES IN US, CANADA, AUSTRALIA

Transitioning to Express Scripts

Russian Pharmaceutical Market Trends in 2017 Track & trace system: additional costs or opportunities? Deloitte CIS Research Centre Moscow, 2017

ANNEX 1: Calculations

Kristin Peck. John Young. Pfizer: Think Digital First. An interview with. EVP WW Business Development and Innovation, Pfizer

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

STANDARDS ORGANISATION OF NIGERIA

Highlights from Selling Honey in PA presentation:

FOR IMMEDIATE RELEASE

Using Your Prescription. Drug Program. Answers to important questions about retail pharmacy and mail order purchasing

Healthcare GTIN Allocation Rules

STANDARDS ORGANISATION OF NIGERIA

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

Official Letter from DOH

WORKSHOP: TRANSPORTING YOUR PRODUCTS TO OVERSEAS MARKETS WHAT EXPORTERS NEED TO KNOW Aug. 24, 2017 Kingston, Jamaica

Essential Update on Contract Manufacturing and Quality Standards CPhI, Paris.

Guidance Document. RMP Template for Farm Dairies Export Eligible Milk. 11 December 2015

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE

GOVERNMENT SECURITY SOLUTIONS SECURE MARKING, AUTHENTICATION, TRACKING AND TRACING TO ASSIST CUSTOMS. Christophe Renard. WCO IT Conference Brisbane

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

September 9, Mr. Mark A. Thierer Chief Executive Officer OptumRx 1600 McConnor Parkway Schaumburg, IL

FREQUENTLY ASKED QUESTIONS

The best quality assurance for meat and animal feed comes from the Netherlands

CHINA. Australia - China Life Science Summit. . Bio & Pharma Logistics

Completing. By the end of this chapter, you will be able to: Introduction. Chapter 16

PROTECTING BRANDS FROM PRODUCT COUNTERFEITING

Global IT Procurement and Logistics. Simplifying the complex: an end-to-end IT supply chain solution

GUIDELINES FOR MEDICAL DEVICES REGISTRATION

*NOTIFY THE DEPARTMENT IN WRITING OF ANY UPDATES

Putting the brakes on strike action The Trade Union Act

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017

EMPLOYMENT OPPORTUNITIES

Strategic Trade Management in ASEAN George Tan

Revised Good Distribution Practice (GDP) with new Consignment Stock Appendix

Presse-Information Press release Information de presse

Important benefit information

Full time (with occasional weekend working required)

From the Permanent Secretary Sir Chris Wormald Department of Health & Social Care

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00

EDQM Overview of our products and services

Transcription:

Controlling Counterfeit Medications A New Role for Pharmacists? Jane Nicholson BRAZIL 2006 1

2

INTERNATIONAL PHARMACEUTICAL FEDERATION FÉDÉRATION INTERNATIONALE PHARMACEUTIQUE Po Box 84200, 2508 AE The Hague, The Netherlands F.I.P. Statement of Professional Standards POLICY STATEMENT ON COUNTERFEIT MEDICINES LISTS:- OBLIGATIONS OF NATIONAL PHARMACY ORGANISATIONS OBLIGATIONS OF PHARMACISTS WORKING GROUP SET UP TO IMPLEMENT FIP POLICY STATEMENT ON COUNTERFEIT MEDICINES JANE NICHOLSON, (Convenor) SABINE KOPP/ VALERIO REGGI (2005), WHO FRANS VAN DER VAART, LMCS BENTE FROKJAER, CPS MIKE ANISFELD, IPS MARION SCHAEFER, Admin S KEITH JOHNSON, PIS DICK TROMP, Chair BPP 3

FIP to: Promote central reporting structure; Identify unreliable wholesalers; Urge Governments to provide robust legislation and tough penalties; Create awareness:- amongst pharmacists/other healthcare workers amongst patients; Collect data by collaboration with pharmacists/ medicines testing laboratories; Publicise available training materials; Reporting form for counterfeit medicines detected in pharmacies Definition: A counterfeit medicine is deliberately and fraudulently mislabelled with respect to identity, composition and/or source. (WHO) Please tick the respective box or write in block letters Rx OTC Source of supply: local wholesaler re-import other pharmacy other source Brand name :... main active substance:... (of the suspected counterfeit medicine) strength:... dosage form:... package size:... batch number:... expiry date:... Is the medicine suspected to be counterfeit or substandard? Counterfeit Substandard Why is this medicine suspected to be counterfeit?... How was the suspected counterfeit medicine detected? Visual inspection Laboratory test Other investigation (specify)... What measures were taken to prevent the risk of possible harm by the suspected counterfeit?:... What is the most likely source for the suspected counterfeit medicine?:... What is the suspected country of origin of the counterfeit medicine?:... Name of Pharmacist (please print). Phone number Date:... Name of the pharmacy:... Street (or P.O.B.)... postal code and city:... 4

EXTRACT OF A LETTER TO FIP MEMBER ASSOCIATIONS IN 2004 FROM GENERAL SECRETARY In a recent report from a Federal Drug Administration (FDA) Task Force, one of the potential weak links is the practice of passing products through multiple wholesalers. Therefore, an additional task for community and hospital pharmacists in your country would be to help identify unreliable wholesalers 5

INDIA TO INTRODUCE DEATH PENALTY FOR PEDDLING FAKE DRUGS WITH MINIMUM PRISON SENTENCES OF 10 YEARS New Delhi Ganapati Mudur India plans to introduce the death penalty for the sale and manufacture of fake and counterfeit medicines that cause grievous harm. The move follows widespread concern that existing regulations pose little deterrence to unscrupulous drug vendors. BMJ 2003; 327:414 (23 rd August) AN EXPERT COMMITTEE HAS PROPOSED A CENTRAL DRUG ADMINISTRATION TO CONTROL LICENSING OF ALL DRUGS AT LEAST 11 STATES IN INDIA DO NOT HAVE LABORATORIES FOR TESTING DRUGS. IN 15 STATES WITH FUNCTIONAL LABORATORIES, ONLY SEVEN ARE ADEQUATELY EQUIPPED AND STAFFED 6

Fake Drugs Flood Bangladesh Bangladesh has 80,000 unlicensed drugstores The Drug Administration Authorities have 25 branches with 40 drug superintendents and inspectors. Estimated 150 million dollars worth of fake drugs produced per annum.( of 5000 drug samples 300 counterfeit) Bangladesh exports to 52 countries 7

8

Trend in Number of FDA Counterfeit Drug Cases 60 58 50 40 30 20 20 22 22 32 No. of Cases 10 0 5 6 6 4 1997 1998 1999 2000 2001 2002 2003 2004 2005 Year Americans use Canadian and Mexican pharmacies because the medicines are cheaper 20 million packages containing medicines are sent annually to patients via the US mail Canadians export an estimated $1.1 billion medicinal products to US residents (about one third of the total Canadian drug bill) Mexico sells 800 million dollars worth to US residents just from border farmacias. 9

Most recent counterfeit medicines found in the USA: PROCRIT LIPITOR SEROSTIM NEUPOGEN EPOGEN C0MBIVIR ZYPREXA VIAGRA DIFLUCAN Counterfeiters use spoke and wheel organisations. Each spoke is not familiar with the next stage. For example, ingredients are produced in one country (e.g. India), the product is formulated in another country, packaged in a third and shipped to a fourth to reach their final destination. Difficult to track!! 10

F.I.P. Website address http://www. pharmacistscombatcounterfeiting.org Proposed Curriculum for a Hands-On Training Programme On Counterfeiting for Pharmacy Students Objectives At the end of the training session/tutorial students should: 1. Be able to define counterfeiting. 2. Have a good knowledge on the health legal and economic implications of counterfeiting. 3. Have a good knowledge of key players in preventing medical products counterfeiting. 4. Be able to identify the myriad roles pharmacists can play in fighting counterfeiting. 5. Develop a strategic plan for life-long learning and updating of skills and knowledge essential to recognise and preventing counterfeiting. 11

FIP WEBSITE LINKS TO WHO WEBSITE www.who.int/medicines/organization/qsm/activities qualityassurance/cft/counterfeit_factsheet.htm and to websites of National Authorities providing information on counterfeit medicines Website of the Authorities in Thailand Thai Drug Division The situation of Thailand in the past 6 years ---------Select Year----------- Pictures of illegal medicines founded/ Unregistered/Smuggling Drug ---------Select illegal medicine below----------- 12

Website of the Authorities in Thailand Thai Drug Division Banned Pharmaceutical Products ---------Select illegal medicine below----------- Counterfeit/Unregistered Veterinary Drug ---------Select illegal medicine below----------- Counterfeit/Unregistered Psycholeptic ---------Select illegal medicine below----------- 13

NIGERIA The National Agency for Food and Drug Administration and Control (NAFDAC), alerts the general public on the identities of some notorious foreign companies who persistently indulge in dumping of fake and counterfeit drugs into the country. Impeccable top-level Federal security report and investigation by NAFDAC have reaffirmed the deep involvement of the under listed companies in the fake and counterfeit drug business. 1. Sinochem, Ningbo Import & Corp. China, Ningbo PR, China 2. Yantai Foreign Economic & Technical Trade Corp. 17-2 Yuhangdng West Road, Yantai, China listed are names and addresses of 5 Chinese Companies 14 Indian Companies 14

To ensure public safety, NAFDAC hereby directs as follows:- Nigerians are barred from importing drugs from companies from these companies forthwith; Any drug(s) imported from these companies will be seized and destroyed by NAFDAC without any conditions. The general public, particularly Drug Importers and Distributors are hereby notified in their own interest, to stop having any business dealings with the aforementioned companies SEAM TANZANIA* Quality Assurance Testing by Minilabs At Port of Entry PRE-LAUNCH OBSERVATIONS Failure rate 13% (counterfeiting contributed To 25% failures) POST-LAUNCH OBSERVATIONS Failure rate 2% Management Sciences for Health 2003* 15

COSTS MINI-LAB KIT 3,000 EURO plus VAT NEAR INFRA-RED SPECTROSCOPY MACHINE 15,000 EURO FIP extract of message to member associations for advise to patients on Internet sales PLAY SAFE WITH MEDICINES Good health is one of the most important issues in everyone s life. If you do not agree now, you will certainly do so as soon as you fall ill. Fortunately, we are in a privileged position today. In most instances, there are medicines available to cure or improve the "ill-health" status. We can find valuable information on the internet about diseases and the various possible treatments. This may help to make decisions if we are able to understand them. However, this is not always easy and if you are not sure about the advice, ask your pharmacist.--- 16

Message to General Public from Royal Pharmaceutical Society of GB and Patient Association Government should: Outline the hazards of buying drugs over the internet without consultation-side effects, risks from counterfeit medicines, interaction with other drugs. Draw public attention to the legal and regulatory framework relating to prescription drugs. Encourage the public to report dubious online pharmacies to the Medicines and Healthcare Products Regulatory Agency (MHRA) and the RPSGB Message to General Public from Royal Pharmaceutical Society of GB and Patients Association Service Providers should: Filter out drug-related spam and remove illegal sites from their servers. Patients should: Buy medicines only from high-street or UK-based online pharmacies. Both these sources are regulated by the RPSGB. Parents should: Install a firewall and e-mail spam filters on the family computer, and assume responsibility for the way it is used. 17

Bottom sticker which remain on the box of the patient Pharmaceutical form and concentration of act.inrg Upper sticker which follow the prescription Company name Progressive number -03 for 2003 (every year The progressive number Start from 00). Movithiol=trademark Of the product E.O.Ф=national drug organisation Number of the product licence Packaging of the product Packaging Security Devices and Tracing Systems Fluorescent fingerprinting Tamper Proof Coloured Stickers and Holograms DNS Bar Coding Readable Micro text in Cartons Printing and 3D Embossing Dry Peel Seals Excellent to monitor the flow and verify product authenticity but will not stop counterfeiting 18

PHARMACEUTICAL SECURITY INSTITUTE The Pharmaceutical Security Institute is a not-for-profit membership organization dedicated to protecting health, sharing information on the counterfeiting of pharmaceuticals, and initiating law enforcement actions through the appropriate authorities. REVIEW OF CURRENT LEGISLATION WORLDWIDE Pharmacy students at University of Illinois have obtained information on legislation from 93 countries A post-graduate law student at DePaul University has spent the summer verifying the data obtained by the students A table in the draft report shows by country, the current legislation, the definition of counterfeit drugs and the penalties for drug counterfeiting The results are to be presented at a Conference in November 2006 at DePaul University with the aim of producing model Anti-Counterfeiting legislation 19

Jamaica s Respond To Counterfeit Questionnaire The Pharmaceutical Society is a professional body representing pharmacists. The Pharmacy Council a body that is concerned with the registering of pharmacist, pharmaceutical students, pharmacies and owner s of pharmacies; the council also regulates the training of pharmaceutical students. The MOH - Pharmaceutical Standards and Regulation Department that body which ensures that the Food and Drug Act and Regulations are followed. Yes this body is also involved in inspection of sub-standard or counterfeit medicines. Each of the above mentioned organizations received a questionnaire. The results were as follows: PSJPCJMOHQuestion #1aNo NoNo- Instead, recently, the S&RD publishes a list of all pharmaceutical preparations which can legally be purchased. This list highlights the manufacturer and the country of origin. The list is readily available to health professionals as well as the public.question #1bNoNoAs mentioned above. Question #2Not to my knowledge No - The curriculum at our Rx School does not train Rx students on this topic partly because this is not popular here in Jamaica. Conclusions Is Controlling Counterfeit Medications a new role for the Pharmacist? unfortunately YES The activities of the Working Party are ongoing. We are determined to keep bringing the subject of Counterfeit Medicines to the attention of all pharmacists. Publicity is central to our work and we need your help to counteract this menace. 20